LODIP: Web-based Learning Module on Optical Diagnosis of Early Colorectal Cancer

Sponsor
Althaia Xarxa Assistencial Universitària de Manresa (Other)
Overall Status
Recruiting
CT.gov ID
NCT05663788
Collaborator
Fundació La Marató de TV3 (Other), Spanish Society of Digestive Endoscopy (Other), Asociación Española de Gastroenterología (Other)
166
12
2
21
13.8
0.7

Study Details

Study Description

Brief Summary

International guidelines recommend deciding the treatment of colorectal lesions based on the estimated histology by endoscopic optical diagnosis. However, the theoretical and practical knowledge on optical diagnosis is not widely expanded

The mail goal of this randomised controlled trial is to compare the pooled sensitivity of optical diagnosis for predicting deep submucosal invasion in large non-pedunculated polyps > 20 mm assessed in routine colonoscopies of gastroenterologists attending a e-learning module (intervention group) vs gastroenterologists who do not (control group)

The main questions the study aims to answer are:
  • Is the pooled sensitivity of optical diagnosis for predicting deep submucosal invasion in large non-pedunculated polyps assessed in routine colonoscopies increased in those gastroenterologists participating in the e-learning module?

  • Is the pooled diagnostic accuracy of optical diagnosis for predicting deep sm invasion in large non-pedunculated polyps ≥ 20 mm assessed in routine colonoscopies increased in those gastroenterologists participating in the e-learning module?

  • In lesions with submucosal invasion, is the en bloc and complete resection rate (R0) increased in those gastroenterologists participating in the e-learning module?

  • In lesions referred to surgery, is the pooled benign polyps rate decreased in those gastroenterologists participating in the e-learning module?

  • In lesions treated with advanced en bloc procedures (ESD, TAMIS, fullthickness resection), is the pooled rate of histology with high-grade dysplasia, intramucosal cancer or submucosal invasion increased in those gastroenterologists participating in the e-learning module?

  • In lesions treated with piecemeal endoscopic resection, is the pooled rate of histology with high-grade dysplasia, intramucosal cancer or submucosal invasion decreased in those gastroenterologists participating in the e-learning module?

  • Is the diagnostic accuracy for predicting deep submucosal invasion in a test with pictures increased after participating in the e-learning module?

The participants (or subjects of study) are gastroenterologists. They will be randomised to do the e-learning course (intervention group) or not (control group).

Researchers will compare clinical outcomes of gastroenterologists participating in the e-learning module vs gastroenterologists not participating in the e-learning module to see if:

  • the pooled sensitivity of optical diagnosis for predicting deep submucosal invasion in large non-pedunculated polyps > 20 mm assessed in routine colonoscopies is increased.

  • the pooled diagnostic accuracy of optical diagnosis for predicting deep sm invasion in large non-pedunculated polyps > 20 mm is increased.

  • the en bloc and complete resection rate (R0) is increased in lesions with submucosal invasion.

  • the pooled benign polyps rate decreased in lesions referred to surgery.

  • the pooled rate of histology with high-grade dysplasia, intramucosal cancer or submucosal invasion increased in lesions treated with advanced en bloc procedures (ESD, TAMIS, fullthickness resection).

  • the pooled rate of histology with high-grade dysplasia, intramucosal cancer or submucosal invasion decreased in lesions treated with piecemeal endoscopic resection.

  • the diagnostic accuracy for predicting deep submucosal invasion in a test with pictures after participating is increased.

Condition or Disease Intervention/Treatment Phase
  • Other: E-learning module
N/A

Detailed Description

Non-pharmacological multi-centre randomised controlled trial. Gastroenterologists who have performed > 300 colonoscopies without supervision and who have finished/will finish the residency in Gastroenterology between 2014 and 2023 will be invited to participate. Gastroenterologists participating in the study will register the optical diagnosis, endoscopic lesions' characteristics, histology and clinical outcomes of consecutive non-pedunculated lesions ≥ 20 mm found in routine colonoscopies during a whole year. Participants allocated in the intervention group will receive a learning module after six months. Those assigned in the control group will not receive any learning module (they will be offered to do it at the end of the study). Pooled sensitivity and diagnostic accuracy of optical diagnosis for predicting deep submucosal invasion, and clinical outcomes in routine colonoscopies will be compared in both groups. Diagnostic accuracy for predicting deep submucosal invasion in a test with pictures before and after participating will also be compared.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
166 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Non-pharmacological multi-centre, stratified (by the centre and experience, with balance randomisation [1:1]), randomised, controlled, parallel trial conducted in Spain.Non-pharmacological multi-centre, stratified (by the centre and experience, with balance randomisation [1:1]), randomised, controlled, parallel trial conducted in Spain.
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Web-based Learning Module to Increase the Accuracy of Optical Diagnosis for Detecting the Invasive Pattern of Colorectal Polyps (LODIP Study). Randomised Controlled Trial
Actual Study Start Date :
Jul 1, 2022
Anticipated Primary Completion Date :
Mar 31, 2024
Anticipated Study Completion Date :
Mar 31, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: E-learning module gastroenterologists

Gastroenterologists participating in the e-learning module

Other: E-learning module
The intervention is a structured e-learning module on a web-based platform (www.trainingopticaldiagnosis.com) that consists of: 10 modules, including theoretical knowledge and multiple exercises. 2 seminars with a tutor (after Module 5 and Module 10) feedback from the tutor on three cases recorded by the participant. 20-images test before and after the content described above (10 Modules, 2 seminars with tutors and feedback on three cases) All the Gastroenterologists participating in the study will predict deep submucosal invasion in their routine colonoscopies and will register clinical outcomes during 12 months. The randomisation and intervention will be conducted 6 months after starting to predict deep submucosal invasion and registering clinical outcomes.

No Intervention: Control group

Gastroenterologists not participating in the e-learning module

Outcome Measures

Primary Outcome Measures

  1. Pooled sensitivity of endoscopic optical diagnosis for predicting deep submucosal invasion in routine colonoscopies [immediately after the colonoscopy]

    Pooled sensitivity of endoscopic optical diagnosis (test assessed by Gastroenterologists according to the ESGE guidelines) for predicting deep submucosal invasion (gold standard measured by the Pathologists according to the WHO criteria) in routine colonoscopies.

Secondary Outcome Measures

  1. Pooled Sensitivity of endoscopic optical diagnosis for predicting deep submucosal invasion [immediately after the colonoscopy]

    Pooled Sensitivity of endoscopic optical diagnosis (test assessed by Gastroenterologists according to the ESGE guidelines) for predicting deep submucosal invasion (gold standard measured by the Pathologists according to the WHO criteria) in routine colonoscopies.

  2. Pooled Specificity of endoscopic optical diagnosis for predicting deep submucosal invasion [immediately after the colonoscopy]

    Pooled Specificity of endoscopic optical diagnosis (test assessed by Gastroenterologists according to the ESGE guidelines) for predicting deep submucosal invasion (gold standard measured by the Pathologists according to the WHO criteria) in routine colonoscopies.

  3. Pooled ROC area of endoscopic optical diagnosis for predicting deep submucosal invasion [immediately after the colonoscopy]

    Pooled ROC area of endoscopic optical diagnosis (test assessed by Gastroenterologists according to the ESGE guidelines) for predicting deep submucosal invasion (gold standard measured by the Pathologists according to the WHO criteria) in routine colonoscopies.

  4. Pooled PPV of endoscopic optical diagnosis for predicting deep submucosal invasion [immediately after the colonoscopy]

    Pooled PPV of endoscopic optical diagnosis (test assessed by Gastroenterologists according to the ESGE guidelines) for predicting deep submucosal invasion (gold standard measured by the Pathologists according to the WHO criteria) in routine colonoscopies.

  5. Pooled NPV of endoscopic optical diagnosis for predicting deep submucosal invasion [immediately after the colonoscopy]

    Pooled NPV of endoscopic optical diagnosis (test assessed by Gastroenterologists according to the ESGE guidelines) for predicting deep submucosal invasion (gold standard measured by the Pathologists according to the WHO criteria) in routine colonoscopies.

  6. Pooled LR+ of endoscopic optical diagnosis for predicting deep submucosal invasion [immediately after the colonoscopy]

    Pooled LR+ of endoscopic optical diagnosis (test assessed by Gastroenterologists according to the ESGE guidelines) for predicting deep submucosal invasion (gold standard measured by the Pathologists according to the WHO criteria) in routine colonoscopies.

  7. Pooled LR- of endoscopic optical diagnosis for predicting deep submucosal invasion [immediately after the colonoscopy]

    Pooled LR- of endoscopic optical diagnosis (test assessed by Gastroenterologists according to the ESGE guidelines) for predicting deep submucosal invasion (gold standard measured by the Pathologists according to the WHO criteria) in routine colonoscopies.

  8. Pooled en bloc resection rate in polyps containing submucosal invasion [immediately after the colonoscopy]

    Pooled en bloc resection rate in polyps containing submucosal invasion found in routine colonoscopies

  9. Pooled complete resection rate (R0) in polyps containing submucosal invasion [immediately after the colonoscopy]

    Pooled complete resection rate (R0) according to the pathologist criteria in polyps containing submucosal invasion

  10. Pooled benign polyps rate in lesions refered to surgery [immediately after the colonoscopy]

    Pooled benign polyps rate in lesions refered to surgery

  11. Pooled rate of histology with high-grade dysplasia, intramucosal cancer or submucosal invasion in lesions treated with advanced en bloc procedures (ESD, TAMIS, fullthickness resection) [immediately after the colonoscopy]

    Pooled rate of histology with high-grade dysplasia, intramucosal cancer or submucosal invasion in lesions treated with advanced en bloc procedures (ESD, TAMIS, fullthickness resection)

  12. Pooled rate of histology with high-grade dysplasia, intramucosal cancer or submucosal invasion in lesions treated with piecemeal endoscopic resection [immediately after the colonoscopy]

    Pooled rate of histology with high-grade dysplasia, intramucosal cancer or submucosal invasion in lesions treated with piecemeal endoscopic resection

  13. Pooled Sensitivity of endoscopic optical diagnosis for predicting deep submucosal invasion in a 20-image test before and after the learning module in the intervention group [immediately after the colonoscopy]

    Pooled Sensitivity of endoscopic optical diagnosis for predicting deep submucosal invasion in a 20-image test before and after the learning module in the intervention group

  14. Pooled Specificity of endoscopic optical diagnosis for predicting deep submucosal invasion in a 20-image test before and after the learning module in the intervention group [immediately after the colonoscopy]

    Pooled Specificity of endoscopic optical diagnosis for predicting deep submucosal invasion in a 20-image test before and after the learning module in the intervention group

  15. Pooled ROC area of endoscopic optical diagnosis for predicting deep submucosal invasion in a 20-image test before and after the learning module in the intervention group [immediately after the colonoscopy]

    Pooled ROC area of endoscopic optical diagnosis for predicting deep submucosal invasion in a 20-image test before and after the learning module in the intervention group

  16. Pooled PPV of endoscopic optical diagnosis for predicting deep submucosal invasion in a 20-image test before and after the learning module in the intervention group [immediately after the colonoscopy]

    Pooled PPV of endoscopic optical diagnosis for predicting deep submucosal invasion in a 20-image test before and after the learning module in the intervention group

  17. Pooled NPV of endoscopic optical diagnosis for predicting deep submucosal invasion in a 20-image test before and after the learning module in the intervention group [immediately after the colonoscopy]

    Pooled NPV of endoscopic optical diagnosis for predicting deep submucosal invasion in a 20-image test before and after the learning module in the intervention group

  18. Pooled LR+ of endoscopic optical diagnosis for predicting deep submucosal invasion in a 20-image test before and after the learning module in the intervention group [immediately after the colonoscopy]

    Pooled LR+ of endoscopic optical diagnosis for predicting deep submucosal invasion in a 20-image test before and after the learning module in the intervention group

  19. Pooled LR- of endoscopic optical diagnosis for predicting deep submucosal invasion in a 20-image test before and after the learning module in the intervention group [immediately after the colonoscopy]

    Pooled LR- of endoscopic optical diagnosis for predicting deep submucosal invasion in a 20-image test before and after the learning module in the intervention group

Eligibility Criteria

Criteria

Ages Eligible for Study:
28 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Gastroenterologists who have performed > 300 colonoscopies without supervision and are in the last training year or had finished the Gastroenterology residency after 2014.
Exclusion Criteria:
  • Endoscopists who have learned the invasive pattern in a centre where endoscopists have published a high diagnostic accuracy for predicting deep submucosal invasion (Japanese centres).

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of North Carolina at Chapel Hill Chapel Hill North Carolina United States 27599
2 National Cancer Center Chuo Tokyo Japan 104-0045
3 Hospital Germans Trias i Pujol Badalona Barcelona Spain 08916
4 Althaia Xarxa Assistencial Universitària de Manresa Manresa Barcelona Spain 08243
5 Consorci Sanitari de Terrassa Terrassa Barcelona Spain 08227
6 Hospital Clínico Universitario Virgen de la Arrixaca El Palmar Murcia Spain 30120
7 Hospital Comarcal de Alcañiz Alcañiz Teruel Spain 44600
8 Hospital Clínic i Provincial de Barcelona Barcelona Spain 08036
9 Hospital Universitario Ramón y Cajal Madrid Spain 28034
10 Hospital Universitario 12 de Octubre Madrid Spain 28041
11 Hospital Universitari i Politècnic La Fe Valencia Spain 46026
12 Nottingham University Hospitals NHS Trust Nottingham Nottinghamshire United Kingdom NG5 1PB

Sponsors and Collaborators

  • Althaia Xarxa Assistencial Universitària de Manresa
  • Fundació La Marató de TV3
  • Spanish Society of Digestive Endoscopy
  • Asociación Española de Gastroenterología

Investigators

  • Principal Investigator: Ignasi Puig, PhD, Althaia Xarxa Assistencial Universitària de Manresa

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
Ignasi Puig, Gastroenterology Consultant, Principal Investigator, Althaia Xarxa Assistencial Universitària de Manresa
ClinicalTrials.gov Identifier:
NCT05663788
Other Study ID Numbers:
  • CEI 19/18
First Posted:
Dec 23, 2022
Last Update Posted:
Dec 23, 2022
Last Verified:
Dec 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Ignasi Puig, Gastroenterology Consultant, Principal Investigator, Althaia Xarxa Assistencial Universitària de Manresa
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 23, 2022